Sector
PharmaceuticalsOpen
₹933Prev. Close
₹924.5Turnover(Lac.)
₹156.72Day's High
₹940Day's Low
₹92652 Week's High
₹1,198.2552 Week's Low
₹659Book Value
₹241.99Face Value
₹5Mkt Cap (₹ Cr.)
1,937.46P/E
31.83EPS
29.01Divi. Yield
0.632 Sep 2024
12:00 AM
AGM
Announcement Date: 02 Sep, 2024
20 May 2024
12:00 AM
Dividend
Dividend Amount: 5.5
Record Date: 17 Sep, 2024
14 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 10.48 | 10.4 | 10.46 | 10.9 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 495.31 | 439.89 | 392.2 | 384.23 |
Net Worth | 505.79 | 450.29 | 402.66 | 395.13 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 759.88 | 630.96 | 513.08 | 465.93 | 427.6 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 759.88 | 630.96 | 513.08 | 465.93 | 427.6 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 18.02 | 13.47 | 9.97 | 6.71 | 8.74 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,727.5 | 96.95 | 4,14,533.1 | 2,000.46 | 0.93 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,790 | 81.58 | 1,80,214.67 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,490.9 | 25.02 | 1,20,427.63 | 1,485.4 | 1.07 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,439.6 | 61.52 | 1,16,404.77 | 474 | 0.17 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,651 | 58.1 | 1,09,463.92 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
Vivek Dhariwal
Whole-time Director
Ashok Kumar Windlass
Managing Director
Hitesh Windlass
Joint Managing Director
Manoj Kumar Windlass
Executive Director
Pawan Kumar Sharma
Non-Exec & Non-Independent Dir
Prachi Jain Windlass
Non-Exec. & Independent Dir.
Srinivasan Venkataraman
Non-Exec. & Independent Dir.
Gaurav Gulati
Company Sec. & Compli. Officer
Ananta Narayan Panda
40/1 Mohabewala Industrial,
Area,
Uttarakhand - 248110
Tel: 91-135-6608000
Website: http://www.windlasbiotech.com
Email: grievance@windlasbiotech.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Windlas Biotech Limited, formerly known as Windlas Biotech Private Limited was incorporated in 2001. The Company got convertedfrom a Private Limited to a Public Limited Company and the name of the Com...
Read More
Reports by Windlas Biotech Ltd
What is the Windlas Biotech Ltd share price today?
What is the Market Cap of Windlas Biotech Ltd?
What is the PE and PB ratio of Windlas Biotech Ltd?
What is the 52 Week High and Low of Windlas Biotech Ltd?
What is the CAGR of Windlas Biotech Ltd?
What is the shareholding pattern of Windlas Biotech Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.